AC
KYTH

Andromeda Capital’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Andromeda Capital’s Portfolio KYTH Stock Details KYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$1.13M Buy
+15,000
New +$1.12M 3.54% 13

Other funds holding KYTH

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WIC
Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Andromeda Capital's KYTH Position: Q3 2015 in Review

Andromeda Capital opened a new position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q3 2015: 15,000 shares worth $1.13M. The stake represents 3.54% of the portfolio and ranks #13 among its holdings.

143 funds tracked by Wall St. Rank hold KYTH as of Q3 2015.

  • Andromeda Capital held 15,000 shares of KYTHERA BIOPHARMACEUTICALS, INC COM worth $1.13M as of Q3 2015.
  • KYTHERA BIOPHARMACEUTICALS, INC COM was a new Andromeda Capital position in Q3 2015.
  • KYTHERA BIOPHARMACEUTICALS, INC COM made up 3.54% of Andromeda Capital's portfolio in Q3 2015, its #13 holding.
  • 143 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q3 2015.

Based on Andromeda Capital's 13F filing for Q3 2015, filed 16 Nov 2015.